Literature DB >> 8506414

The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi.

D E Elder1, W H Clark, R Elenitsas, D Guerry, A C Halpern.   

Abstract

Intermediate lesions of melanocytic tumor progression are potential precursors, simulants, and risk markers of melanoma. The clinical, public health, and biologic significance of intermediate lesions warrants their continued recognition and study, although improved schemata for their clinical and histological coding are needed. Blurred boundaries are inherently problematic to the categorization of lesions occurring along a stepwise pathway of increasing clinical and histological atypia. Nevertheless, the concepts of melanocytic dysplasia and of radial growth phase (in situ and microinvasive) melanoma are important to the classification of intermediate lesions of melanocytic tumor progression. Conceptually, these lesions are clearly separable from early and late lesions and from one another, and there is evidence that criteria distinguishing them can be reproducibly applied. Analysis of these intermediate lesions suggests that they represent responses to events (perhaps mutational) induced by ultraviolet light in constitutionally hypersensitive individuals, supporting epidemiological data that implicate sunlight as an etiologic agent for most melanomas. The continuing rigorous application of the methodologies of epidemiology and basic science to the study of these lesional steps will likely lead to the recognition of biologic markers to better distinguish benign from malignant melanocytic lesions.

Entities:  

Mesh:

Year:  1993        PMID: 8506414

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  11 in total

1.  A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. CRC Melanoma Pathology Panel.

Authors: 
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

2.  Macroscopic spectral imaging and gene expression analysis of the early stages of melanoma.

Authors:  P Yang; D L Farkas; J M Kirkwood; J L Abernethy; H D Edington; D Becker
Journal:  Mol Med       Date:  1999-12       Impact factor: 6.354

3.  Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesions.

Authors:  J M Kirkwood; D L Farkas; A Chakraborty; K F Dyer; D J Tweardy; J L Abernethy; H D Edington; S S Donnelly; D Becker
Journal:  Mol Med       Date:  1999-01       Impact factor: 6.354

4.  Telomerase activity in melanocytic lesions: A potential marker of tumor biology.

Authors:  P Rudolph; C Schubert; S Tamm; K Heidorn; A Hauschild; I Michalska; S Majewski; G Krupp; S Jablonska; R Parwaresch
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

5.  A case of oral mucosal melanoma. Clinical and dermoscopic correlation.

Authors:  Tamar Hajar-Serviansky; Daniela Gutierrez-Mendoza; Iris Lavinia Galvan; Lorena Lammoglia-Ordiales; Adalberto Mosqueda-Taylor; Maria de Lourdes Hernandez-Cázares; Sonia Toussaint-Caire
Journal:  J Dermatol Case Rep       Date:  2012-03-27

Review 6.  Use of liposomes as drug delivery vehicles for treatment of melanoma.

Authors:  Melissa A Tran; Rebecca J Watts; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2009-05-22       Impact factor: 4.693

Review 7.  Melanoma epidemiology.

Authors:  Margaret A Tucker
Journal:  Hematol Oncol Clin North Am       Date:  2009-06       Impact factor: 3.722

8.  Study of Nevi in Children (SONIC): baseline findings and predictors of nevus count.

Authors:  Susan A Oliveria; Jaya M Satagopan; Alan C Geller; Stephen W Dusza; Martin A Weinstock; Marianne Berwick; Marilyn Bishop; Maureen K Heneghan; Allan C Halpern
Journal:  Am J Epidemiol       Date:  2008-11-10       Impact factor: 4.897

9.  α-Methylacyl-coenzyme A racemase (AMACR, p504s) is a marker to distinguish malignant melanomas from dysplastic nevi and melanocytic nevi.

Authors:  M Abbas; E M Ploch; J Wehling; E Schipper; S Janciauskiene; H H Kreipe; D Jonigk
Journal:  Tumour Biol       Date:  2014-08-24

10.  Lessons learned from studies of the development of early melanoma.

Authors:  Toshiaki Saida
Journal:  Int J Clin Oncol       Date:  2005-12       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.